23
Jun 2026
Revolutionary protective shoe concept provides increased comfort and minimizes strain
A revolutionary protective shoe concept adapts to the needs of users in a new way and provides increased comfort and minimizes strain.
Stay Informed!
23
Jun 2026
TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio
TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million).
23
Jun 2026
The menstrual cycle changes heart-rate variability but not strength
Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states remain largely unchanged.
23
Jun 2026
Longer breastfeeding links to fewer ADHD symptoms in children
Longer durations of full breastfeeding are linked to fewer ADHD symptoms in children, suggesting early feeding patterns may influence neurodevelopment.
23
Jun 2026
Elite athletes with higher vitamin D show healthier lipid profiles
Higher serum 25-hydroxyvitamin D levels were independently associated with lower LDL-C, triglycerides, and lipoprotein(a) in 773 male professional athletes. The cross-sectional study cannot establish causality, but it suggests that vitamin D status may be linked to cardiovascular risk-related lipid markers, even in elite athletic populations.
23
Jun 2026
Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men
A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.
23
Jun 2026
50-year review shows global Ebola spread remains rare despite outbreak fears
Researchers reviewed Ebola disease cases outside Africa from 1976 to May 2026 and found only 28 confirmed epidemic-linked cases, most involving medical evacuation or occupational exposure. Only four latent travelers were diagnosed after border screening, suggesting that undetected intercontinental spread remains rare when outbreaks are controlled at source.
23
Jun 2026
Andes virus cases on MV Hondius highlight hidden risks of confined travel
A Eurosurveillance report describes a multi-country response to an Andes virus outbreak linked to the Dutch-flagged expedition cruise ship MV Hondius, with 13 cases and three deaths reported as of June 18, 2026. Investigators found evidence consistent with an initial zoonotic infection before embarkation, followed by likely person-to-person transmission among passengers and crew in a confined ship setting.
22
Jun 2026
Insilico and SK Biopharmaceuticals partner to develop AI-driven neuroimmune therapies
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with groundbreaking drug research, development, and commercialization worldwide, announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates in the neuroimmune area of the central nervous system.
22
Jun 2026
Accelerated biological aging may drive rising early-onset cancer risk
Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation.
